$94.20
2.32 (-2.40%)
Last updated: Apr 16, 2026 00:44
Fundamentals Overview
Zimmer Biomet Holdings, Inc. is in the middle of its 52-week range with premium valuation, trending downward today.
Valuation premium
Intrinsic value (DCF)
+361.6% upside vs price
Profitability
Risk (Beta)
0.61 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +361.6% upside vs price · Analyst grade: A- · 3M vs Healthcare sector: +9.1%
Pressures (Sell):
Sentiment weakening (3 downgrades)
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: A-. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 5, Equal Weight: 1, Hold: 4, In Line: 2, Market Outperform: 1, Market Perform: 1, Neutral: 6, Outperform: 4, Sell: 3, Underweight: 3.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $434.87; current price is $94.20. That’s a +361.6% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 26.46 |
| DCF value (model) | $434.87 (361.6% upside) |
| PEG (TTM) | N/A |
| P/B (TTM) | 1.46 |
| P/S (TTM) | 2.24 |
| P/FCF (TTM) | 9.97 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 1.98 |
| Quick Ratio (TTM) | 1.1 |
| Cash Ratio (TTM) | 0.23 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 8.57% |
| Gross margin (TTM) | 69.71% |
| Operating margin (TTM) | 14.96% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for ZBH.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| BTIG | downgrade | Buy | Neutral | 2026-03-23 |
| Barclays | maintain | Underweight | Underweight | 2026-02-12 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-02-11 |
| Citigroup | maintain | Neutral | Neutral | 2026-02-11 |
| Needham | maintain | Hold | Hold | 2026-02-10 |
| BTIG | maintain | Buy | Buy | 2026-02-10 |
| UBS | maintain | Sell | Sell | 2026-01-28 |
| Bernstein | maintain | Market Perform | Market Perform | 2026-01-09 |
| BTIG | maintain | Buy | Buy | 2026-01-08 |
| Evercore ISI Group | upgrade | In Line | Outperform | 2026-01-05 |
| Baird | downgrade | Outperform | Neutral | 2025-12-16 |
| Citigroup | maintain | Neutral | Neutral | 2025-12-11 |
| Canaccord Genuity | maintain | Hold | Hold | 2025-11-10 |
| RBC Capital | maintain | Outperform | Outperform | 2025-11-06 |
| Barclays | maintain | Underweight | Underweight | 2025-11-06 |
| JP Morgan | downgrade | Overweight | Neutral | 2025-11-06 |
| UBS | maintain | Sell | Sell | 2025-11-06 |
| BTIG | maintain | Buy | Buy | 2025-11-05 |
| Barclays | maintain | Underweight | Underweight | 2025-11-05 |
| Canaccord Genuity | maintain | Hold | Hold | 2025-10-22 |
| BTIG | maintain | Buy | Buy | 2025-10-13 |
| Evercore ISI Group | maintain | In Line | In Line | 2025-10-07 |
| Stifel | maintain | Buy | Buy | 2025-09-19 |
| Raymond James | maintain | Outperform | Outperform | 2025-08-08 |
| RBC Capital | maintain | Outperform | Outperform | 2025-08-08 |
| UBS | maintain | Sell | Sell | 2025-08-08 |
| Evercore ISI Group | maintain | In Line | In Line | 2025-07-08 |
| Canaccord Genuity | maintain | Hold | Hold | 2025-05-12 |
| JMP Securities | maintain | Market Outperform | Market Outperform | 2025-05-07 |
| Goldman Sachs | maintain | Neutral | Neutral | 2025-05-06 |